Official Report 860KB pdf
The final item of business is a members’ business debate on motion S7M-01572, in the name of Fulton MacGregor, on developing a national Scottish Fontan service and transplant pathway. The debate will be concluded without any question being put. Any member who wishes to speak in the debate should press their request-to-speak button now. I call Fulton MacGregor to speak for up to seven minutes.
Motion debated,
That the Parliament recognises the life-saving role of the Fontan procedure for children born with complex congenital heart disease and a single-ventricle circulation; notes that the Fontan operation is a form of open-heart surgery, which enables oxygen-poor blood returning from the lower body to bypass the heart and flow directly to the blood vessels of the lungs, separating oxygen-poor and oxygen-rich blood and significantly improving oxygen levels throughout the body; recognises that, following Fontan surgery, many children experience improved oxygenation, energy and quality of life, allowing them to survive into adulthood; further recognises, however, that the Fontan circulation is a form of palliation rather than a cure and that people living with it require lifelong specialist surveillance and multidisciplinary care; notes what it sees as the growing current and foreseeable clinical needs of people in Coatbridge and Chryston and across Scotland who are living with Fontan circulation and complex congenital heart disease; understands that international prevalence data suggest that between 300 and 400 individuals in Scotland currently live with it, with adult survival now up to 90%, resulting in a growing adult population at increasing risk of Fontan-associated complications and multi-organ disease; notes that complications can include progressive heart failure, arrhythmias, protein-losing enteropathy, plastic bronchitis, kidney dysfunction and liver disease, with up to 50% of adult Fontan patients developing clinically significant liver disease; understands that approximately 20 to 30% might ultimately require multi-organ transplantation such as heart, liver and/or lung transplants; believes that the increasing number of adults living with Fontan circulation represents a significant and evolving clinical need for NHS Scotland; notes with concern that Scotland currently lacks a dedicated national pathway for failing Fontan circulation and complex congenital heart disease requiring transplantation, resulting in some patients being referred outwith the country, most commonly to specialist centres in England; recognises the physical, emotional, financial and logistical burden that this can place on patients and families, including prolonged separation, fragmented continuity of care and ongoing cross-border follow-up requirements; notes what it sees as the absence of a formalised Scottish shared care model for post-transplant surveillance and long-term management; acknowledges Scotland’s existing strengths, including the Scottish Adult Congenital Cardiac Service (SACCS), established heart transplant infrastructure at the Golden Jubilee National Hospital, experienced cardiothoracic surgical programmes and national service planning capability; believes that these existing strengths provide a strong foundation for developing a coordinated Scottish Fontan service; further believes that there is a strategic opportunity to develop a national Scottish Fontan hub to provide structured lifelong surveillance, early identification of Fontan-associated complications, multidisciplinary assessment, risk stratification, transplant planning and coordination, and post-transplant shared care; considers that such a model could improve patient safety, equity of access, continuity of care and clinical outcomes, while supporting the principle of providing specialist care as close to home as clinically appropriate; notes the view that, in the context of any future changes to the organisation or provision of specialist health services in Scotland, particular consideration should be given to the arrangements required to ensure continued access to specialist transplant centres in England for patients from Scotland, where clinically appropriate, and notes the view that clear and sustainable cross-border pathways should form an important part of the long-term planning for Fontan and complex congenital heart disease services, and acknowledges the calls on the Scottish Government to engage with NHS Scotland, SACCS leadership, transplant centres, relevant clinical specialists and patients and families affected by Fontan circulation to undertake a feasibility assessment for the development of a national Fontan hub and structured complex congenital heart disease transplant pathway, including consideration of workforce planning, specialist training, infrastructure, cross-border arrangements, research and data collection, and the long-term sustainability of the service.
17:52
Thank you to those colleagues across the chamber who supported my motion on developing a national Scottish Fontan service and transplant pathway—[Interruption.]
Is there a problem with the microphone system?
We could not hear you either, Presiding Officer.
We will take a short pause to sort it out.
Let us start again. I call Fulton MacGregor to speak for up to seven minutes.
Thank you, Presiding Officer. Is that better?
On a point of order, Presiding Officer. It is still not working.
Thank you. That is helpful. I think that Mr MacGregor has—
Broken the system. [Laughter.]
—sorted the technical hitch.
Thank you, Presiding Officer. [Interruption.] Is it still not working?
I suggest that the member move to another console if other members think that their consoles are working. [Interruption.] I think that we have a technical problem, so I will suspend the meeting briefly, so that we can resolve the issue.
17:54
Meeting suspended.
17:58
On resuming—
I call Fulton MacGregor again, for up to seven minutes.
Thank you, Presiding Officer.
I thank the colleagues across the chamber who supported my motion on developing a national Scottish Fontan service and transplant pathway. Because of their support, I am pleased to bring this motion to the chamber this evening.
The motion recognises the life-saving importance of the Fontan procedure for children who are born with complex congenital heart disease, and it calls for a more co-ordinated and sustainable approach to supporting those living with Fontan circulation here, in Scotland.
We are joined by a number of people in the public gallery for whom this subject is an integral part of their lives. I reassure them that these technical issues do not usually happen. I also thank my constituent Nicole Egan, who sadly could not be here tonight. Her tenacity ensured that the debate could take place this evening. Nicole, the attendees who are here tonight and the countless others who will be watching online will know all too well that, for many families, a diagnosis of complex congenital heart disease is the beginning of an incredibly difficult and frightening journey. Parents are faced with uncertainty, difficult decisions and the prospect of their child undergoing major surgery at an exceptionally young age.
For children born with single-ventricle heart conditions, the Fontan procedure can be life saving. It is a remarkable surgical intervention that allows children who might otherwise have had a very limited life expectancy to survive, grow up and experience many of the opportunities that other children take for granted. The procedure works by redirecting oxygen-poor blood returning from the body directly to the lungs, bypassing the heart. That allows oxygen-rich blood to circulate around the body more effectively, significantly improving oxygen levels and, in many cases, improving a child’s energy, physical capability and quality of life.
It is difficult to overstate what that means to families. The Fontan procedure has transformed the prospects of children who are born with some of the most complex forms of congenital heart disease. Children who may once have faced an uncertain future are now growing into teenagers and adults, pursuing education, building relationships, entering employment and planning their futures. We must acknowledge that that is an extraordinary achievement of modern medicine.
However, we must also recognise that the Fontan procedure is a mitigation, not a cure. Living with Fontan circulation brings lifelong medical challenges. The circulation works differently from that of a person with a normal heart, and, over time, that places additional pressure on the heart and other organs. As patients grow older, they can develop serious complications including heart failure, abnormal heart rhythms, blood clots, kidney dysfunction, protein-losing enteropathy, plastic bronchitis and progressive liver disease. Fontan-associated liver disease is a particularly significant concern. The altered circulation increases pressure in the veins, making it more difficult for blood to drain from the liver. That can lead to scarring and, in some cases, more serious liver complications.
Lifelong follow-up is essential. Monitoring can involve blood tests, heart scans, liver imaging, MRI investigations and other specialist assessments. Importantly, that care often requires cardiologists to work alongside liver specialists and other clinical professionals. I stress that it is not an occasional follow-up—it is lifelong, complex and increasingly important as patients reach adulthood.
Although we can consider the Fontan procedure as a success of modern medicine, it has created a new and growing responsibility for our health service. International prevalence data suggest that between 300 and 400 people in Scotland are currently living with Fontan circulation. Improvements in surgical techniques and long-term survival mean that an increasing number of those individuals are now reaching adulthood.
Adult survival rates exceeding between 85 and 90 per cent are encouraging, but they mean that we must prepare for the growing clinical needs of that population. Estimates suggest that between approximately 20 and 30 per cent of people who are living with Fontan circulation may ultimately require consideration for transplantation, potentially involving the heart, liver and, in some circumstances, the lungs. That will present a significant challenge for NHS Scotland.
Scotland does not currently have a dedicated national pathway for failing Fontan circulation and complex congenital heart disease requiring transplantation. As a result, some patients must be referred outside Scotland, most commonly to specialist centres in England. I make it clear that access to specialist expertise wherever it is available is essential, and cross-border arrangements will continue to play an important role. Patients must never be denied the treatment that they need because of geographical boundaries.
However, we must recognise the additional burden that travelling elsewhere in the United Kingdom can place on patients and their families. For someone who is already living with a serious and complex heart condition, travelling long distances outside their own country for specialist appointments, assessments or major treatment can be physically and emotionally exhausting. For families, there can be considerable financial pressures, accommodation costs, time away from work and prolonged periods of separation from their usual support networks.
There are also questions about continuity of care. When treatment involves different health boards, hospitals and clinical teams, ensuring that information is shared effectively and that patients receive consistent follow-up becomes even more important. Those administrative challenges affect people's lives, their families and their experience of healthcare at an already vulnerable time. That is why I believe that Scotland needs to look seriously at developing a national Fontan hub. Scotland is not starting from scratch in that—we already have significant strengths on which to build.
The Scottish adult congenital cardiac service provides an important foundation for specialist congenital heart disease care. We also have established heart transplant infrastructure at the Golden Jubilee national hospital, experienced cardiothoracic surgical teams and the ability to plan and co-ordinate national specialist services. I believe that we should bring those strengths together. A national Fontan hub could provide a co-ordinated approach to lifelong surveillance, early identification of complications, multidisciplinary assessment, risk stratification and transplant planning. It could also help to establish clearer pathways between specialist centres, local hospitals, primary care and transplant services, ensuring that patients receive the right expertise at the right time.
Crucially, a national hub would not mean that every appointment or investigation would have to take place in one hospital, because that would still require many patients to travel long distances, given the size and rurality of Scotland. Instead, the principle should be to provide specialist care as close to home as is clinically appropriate while ensuring that patients can access highly specialised interventions when they need them. Given the relatively small number of patients involved, we should be able to offer that care as locally as possible. For those throughout Scotland, access to specialist expertise should not depend on where they happen to live or how easily they can travel.
We must also consider what happens when a patient undergoes a transplant. Transplantation is not the end of the healthcare journey—it brings its own lifelong requirements, including medication, monitoring, specialist appointments and surveillance for complications. Scotland needs to consider how a formalised shared-care model could support patients following transplantation, particularly those who have received treatment at specialist centres elsewhere in the UK.
Clear arrangements between Scottish services and English transplant centres would help to protect continuity of care, avoid unnecessary duplication and give patients and families confidence that their long-term needs are being properly managed. That is especially important in the context of any future changes to the organisation or provision of specialist health services, and cross-border access must be protected through clear, sustainable arrangements based on clinical need.
Finally, I stress that we must listen to the people who live with these conditions every day. Patients and families understand the realities of Fontan circulation in a way that statistics alone cannot capture, and their experiences should help to shape the services that we develop. The Scottish Government should, therefore, now engage with NHS Scotland, the Scottish adult congenital cardiac service, transplant centres, clinical specialists and affected families to undertake a proper feasibility assessment. That assessment could consider workforce planning, specialist training and long-term financial sustainability.
The Fontan procedure has given thousands of people around the world something that previous generations could not have imagined: the opportunity to survive childhood and live well into adulthood, despite having some of the most complex forms of congenital heart disease. We should celebrate that achievement, but we must recognise the responsibility that comes with it. It cannot be right that the success of life-saving surgery is followed by uncertainty about where patients will receive the specialist care that they need as adults.
We have the clinical expertise, the existing infrastructure and the opportunity to develop a better, more co-ordinated approach in Scotland, and I hope that the Minister for Mental Wellbeing, Public Health, Sport, Alcohol and Drugs will be able to reflect on that in summing up.
18:07
I thank Fulton MacGregor for securing this important debate. I want to speak about what living with Fontan circulation means and why planning now is important if we are to meet the needs of a growing population of patients.
One of the great success stories of modern medicine is that children who are born with conditions that would once have been fatal are now surviving into adulthood. The Fontan procedure has transformed thousands of lives around the world: it has enabled children to attend school, pursue careers and start families and, ultimately, to do things that would have been unimaginable only a generation ago. The success of that surgery has changed the challenge before us. It is no longer about how we help children survive, but rather about how they can thrive. People living with Fontan circulation often describe the condition as an invisible illness. To those around them, they may appear healthy and active, but behind that can be frequent hospital appointments and anxious uncertainty.
Scotland is fortunate to have world-class expertise in congenital heart disease. The Scottish adult congenital cardiac service at the Golden Jubilee national hospital acts as a national centre for adults with congenital heart disease and provides specialist assessments and surgery for patients across Scotland. We should all recognise the investment from both the Scottish Government and NHS Scotland that has enabled those specialist services to be deployed. The establishment of a service such as SACCS demonstrates what can be achieved if country-wide expertise is brought together to provide a strong foundation on which the next stage of development can be built.
Healthcare Improvement Scotland’s congenital heart disease standards recognise the importance of seamless care, shared care pathways, multidisciplinary working and effective transition from paediatric to adult services. Those principles align closely with what patients who are living with Fontan circulation are asking for. The reality is that the number of adults who are living with complex congenital heart disease will grow. Public Health Scotland data shows that congenital heart disease remains the most common group of congenital conditions identified in Scotland. Advances in diagnosis, surgery and long-term care mean that more children are surviving and living longer than ever before. That is obviously something to celebrate, but it also demands long-term planning.
For patients and families in Fife, those challenges are familiar. Although specialist treatment is often delivered through national services, much of the day-to-day support takes place closer to home, through national health service local services.
NHS Fife already plays an important role in supporting those who live with heart conditions and in connecting local care with specialist services elsewhere in Scotland. As one of Fife’s MSPs, I know how important it is that people can access specialist expertise without feeling disconnected from local services. When people are required to travel significant distances for highly specialised treatment, the impact extends to the whole family. That impact becomes even greater when transplantation is considered, as that is a lifelong commitment involving medication and monitoring.
For families of those who are already navigating a complex congenital heart condition, uncertainty about where their care will be delivered or who will co-ordinate it can create additional stress at an already difficult time. That is why a proposal for a national Scottish Fontan hub is so important. Early identification of complications, co-ordinated multidisciplinary assessment, strong data collection, improved research opportunities and a structured transition between services all have the potential to improve outcomes. A hub would also improve the experience of patients and families who are navigating complex healthcare journeys.
People who live with a Fontan circulation have already overcome extraordinary challenges. They and their families deserve a system that recognises their needs, anticipates their future demand and supports them throughout their lives.
Scotland has clinical expertise, infrastructure and a successful national specialist service to build on. I hope that the Scottish Government will positively consider the call for a feasibility assessment and will work with clinicians, patients and families to develop a co-ordinated national approach that is fit for the future.
18:11
I thank Fulton MacGregor for bringing his important motion to the chamber and giving us the opportunity to discuss the Fontan procedure and understand more about congenital heart disease and the single-ventricle conditions that require the procedure. I also have to say that it is the longest and most detailed motion that the Parliament has considered, and it could not be on a more important subject.
As the motion mentions, the immediate benefit for children who are born with the condition is the lift in energy that comes with greater oxygenation, greater independence and the ability to live a fuller life. With that comes improved life expectancy. Although many go on to require transplant surgery, many do not, which is remarkable.
For many families, it will be the beginning of a lifelong relationship with specialist healthcare, to monitor progress and assess for any deterioration or complication from the procedure. Although, rightly, we celebrate advances in surgical techniques and medical technology, we should also recognise the highly skilled people behind those things—the clinicians who dedicate their careers to understanding particular conditions, developing their expertise and finding better ways to treat patients. For people who live with Fontan circulation, that expertise needs to extend across a number of disciplines. Cardiologists, cardiac surgeons, transplant specialists, nurses, hepatologists and many others will have an important role to play.
However, it is not enough simply to have those specialists available. They need to be able to work together, share information and ensure that patients are not falling between different services or having to navigate an increasingly complicated health system.
The motion makes many important points about the pathways between Scotland and England. I hope that the minister will absolutely agree that every care will be given to make sure that cross-border pathways remain open.
I will touch briefly on organ donation, which is a reality for 20 to 30 per cent of Fontan procedure recipients. Scotland’s move to an opt-out system in 2021 was an important step in recognising the life-saving difference that organ donation can make. We should celebrate the generosity of donors and their families and continue to encourage conversations about donation, so that people understand the choices that are available to them.
As medicine improves and as people live longer with increasingly complex conditions, organ donation will become a more normalised part of the NHS. For those with a Fontan procedure, congenital heart disease or a single-ventricle condition, a heart transplant will be a very real possibility. However, as medicine advances, more of us will benefit from a well-staffed transplant service if we are unfortunate enough to need it. That makes workforce planning particularly important. We need to be thinking now about the surgeons, nurses, transplant co-ordinators and other specialists we will need in the years ahead and about how we will ensure that Scotland has the capacity and capability to provide the services that patients require.
However, we also need to be pragmatic about how we get there. If some of the required capability, capacity or specialist knowledge is currently concentrated in centres in England, we should be looking at how NHS Scotland can work with those centres to share expertise and, as Fulton MacGregor has suggested, develop our own workforce and hubs. That could mean training exchanges, joint clinical pathways, shared research or opportunities for Scottish clinicians to spend time working alongside established specialist teams.
The opportunity to debate a rare and challenging condition has been welcome. Hundreds of people in Scotland live with a Fontan procedure, and we absolutely owe it to them to get it right now and in the future. Specialised surgical teams, a hub to co-ordinate services, as suggested by Fulton MacGregor, and a decent workforce plan that makes sure that we have all the specialist staff for the future—all are important. However, above all, we should continue to work collaboratively across borders in the interests of patients.
18:16
I thank Fulton MacGregor for bringing the debate to the chamber, and I thank the families who are here today for the discussion and to show what it is about. To be honest, I had not heard of Fontan syndrome specifically, and it has been important to look at it.
Something to celebrate is the brilliant success story of surgeons in the UK and beyond. In a few decades, treatment has been developed so that 90 per cent of people who have the complex can reach adulthood. That is a huge change over a few decades.
Others have talked about the team behind that—not just the surgeons, but the teams that support the families, preparing the children for that surgery and, later, for other kinds of surgery. It seems absolutely right that we should have specialist teams. It is good that, in the Golden Jubilee hospital and the Scottish adult congenital cardiac service, we already have multidisciplinary teams who will get to know the families and will be there for them. In times of constraint, it can be easy not to have teams of all the necessary specialists, so we need to make sure that they are there.
The motion’s call for a feasibility study into a national Fontan hub recognises that we do not have the appropriate numbers of patients to consider setting up the transplant surgery and Fontan procedure in Scotland; however, people have to be prepared for it and have to be transported to Newcastle, at the moment, where they need to be supported. Their families need to be supported as well. It is about integrated long-term planning.
As Jackie Baillie pointed out, the motion is very detailed about what is required, and we must look at the services across the border as well. Interestingly and coincidentally, the Health, Care and Sport Committee today considered a legislative consent motion on the UK Health Bill. The Government has looked at it and has negotiated with the UK Government. Some of it—which the minister may refer to—concerns the crossing of NHS services from Scotland into England and vice versa, and how that would be overseen, rightly, by Scottish Government ministers. We must always have a way to do that. At the end of the day, Scotland has a relatively small population. For such a rare condition, we must have the ability to smoothly help people to be referred. We have sometimes heard of people experiencing delays in other specialist services. That makes the pathway to which Fulton MacGregor referred absolutely critical, so that there is a seamless way of helping people to move on at what is a stressful and difficult time for families.
Another aspect is about supporting patients and families to go down to Newcastle and, within Scotland, to attend the Golden Jubilee hospital, in Glasgow. There is an important point about funding, which is referred to in the motion. It is critical that families can be reimbursed, but that is the sort of thing that sometimes falls between two stools, and people might then start discussing where the money should come from. There is a route for reclaiming money for families of children who are in hospital overnight. However, many families might not be able to support themselves in those conditions, so it is worth considering how money can be provided up front. We have discussed that more generally in relation to children going into hospital. I would like reassurance that, at such a difficult time for families, they will not need to think about where to get the money to travel with the child. That can make all the difference.
I thank Fulton MacGregor for bringing the issue to the Parliament, and I thank the families for giving us information. I wait with interest to hear what the minister will say.
18:21
I welcome the opportunity to speak in this important debate, and I thank members for their contributions. In particular, I thank Fulton MacGregor for lodging the motion and highlighting the experiences of people across Scotland who are living with Fontan circulation and complex congenital heart disease. I cannot help but reflect on Jackie Baillie’s observation about the motion being potentially the longest one that the Parliament has ever dealt with for a members’ business debate. That reflects the complexity involved in the ongoing care of people with those requirements.
I recognise the patients, families, carers, clinicians and charities whose experience has helped to inform the debate. It is great to have people with a particular interest join us in the public gallery. Their voices are essential in helping us to understand the progress that has been made and the evolving needs of people who live with congenital heart disease.
As other members have said, the Fontan procedure represents one of the great achievements of modern medicine. Thanks to advances in surgery, clinical care and long-term follow-up, many people who are born with complex congenital heart disease are living longer and fuller lives than ever before. As the number of adults living with Fontan circulation grows, lifelong specialist monitoring and co-ordinated multidisciplinary care become increasingly important. The Scottish Government recognises the importance of providing high-quality person-centred care for people who are living with congenital heart disease.
Scotland already benefits from specialist services, including the Scottish adult congenital cardiac service and the Scottish national advanced heart failure service at the Golden Jubilee national hospital, and those are supported by dedicated teams right across NHS Scotland. Since 2021, the Scottish Government has funded the Scottish cardiac audit programme, which is delivered by Public Health Scotland and which includes data from the Scottish adult congenital cardiac service and supports service monitoring, benchmarking and quality improvement. Data linkage with the congenital and rare conditions registry service for Scotland—CARDRISS—is also helping to improve our understanding of the congenital heart disease population in Scotland and, crucially, to inform future service development.
As the motion makes clear, some people living with complex congenital heart disease may, over time, require increasingly specialised interventions, including transplantation. Heart transplantation for patients with complex congenital heart disease, including those who have undergone the Fontan procedure and have failing Fontan circulation, is among the most specialised forms of transplantation undertaken anywhere in the UK. The operations require highly specialised expertise, multidisciplinary teams and extensive experience in managing complex congenital conditions before, during and after transplantation.
For that reason, transplantation for those patients is provided through a UK-wide commissioned service that is based at the Freeman hospital, in Newcastle. That arrangement is supported by clinical experts and by the NHS blood and transplant cardiothoracic advisory group. The rationale is clear: those are rare and exceptionally complex procedures, so concentrating activity in a single specialist centre helps to maintain the expertise required to deliver safe care. The Scottish Government’s current position is that that arrangement provides the best possible service with the lowest clinical risk for patients who require those highly specialised operations.
I recognise the strength of feeling on the issue and understand why patients and families may want to have more of that specialised care being delivered within Scotland. Those views reflect absolutely understandable concerns about treatment taking place away from home and from support networks at what can be an incredibly difficult time. We recognise the challenges associated with treatment that happens away from home and we know that travelling outside Scotland for specialist treatment can place significant practical and emotional burdens on patients and their families. Time away from family and support networks, periods of living with uncertainty, and the logistical challenges of accessing highly specialised care are all issues that deserve careful consideration.
At the same time, decisions about highly specialised transplant services must be guided by clinical evidence and patient safety. The need to maintain expertise in rare and exceptionally complex procedures at established specialist centres remains a vital consideration in securing the best possible outcomes for patients.
I recognise the Government’s position and I know that the minister has gone to great lengths to outline the reason for that position. In my own remarks, I asked the Government to undertake a feasibility study into what is being asked for here. Are the minister and the Government open to that?
I assure Mr MacGregor that there is continuous improvement of the pathways. We work closely with NHS boards, specialist clinicians and partners from across the UK to ensure that the pathways into specialist services are as effective and supportive as possible. Our focus continues to be on ensuring that Scottish patients have timely access to the specialist care they need while also strengthening co-ordination, communication and shared care arrangements, so that as much care and support as possible can be provided closer to home when that is clinically appropriate.
There may well be opportunities to strengthen service co-ordination, surveillance arrangements and the support for people who are living with Fontan circulation, but any future development must recognise the importance of maintaining access to the nationally designated expertise available through the Freeman hospital, where the transplantation service for those with congenital heart disease is concentrated in one centre serving the whole of the UK.
The Scottish Government is keen to engage with clinicians, NHS Scotland and, in particular, patients to understand how services can improve. We recognise the importance of ensuring that people living with congenital heart disease receive co-ordinated care throughout their lives and that transitions between services are managed as smoothly as possible.
This debate has highlighted both the significant progress that has been achieved and our shared commitment to ensuring that people living with complex congenital heart disease receive the highest standards of care throughout their lives. The Scottish Government will continue working with NHS Scotland and with clinicians and partners across the UK to ensure that patients have access to safe, high-quality specialist care, and we will continue listening to patients, because that is an important aspect of improving services.
In conclusion, I again thank Fulton MacGregor for securing this debate and thank all members who have contributed. The experiences shared today have made an important contribution to our understanding of how services can evolve to meet the needs of patients and families now and in the future.
Meeting closed at 18:30.
Previous
Decision Time